Crossmark

Study protocol of a German multi-center, observer-blind, randomized, and actively controlled parallel-group trial comparing maintenance electroconvulsive therapy to treatment as usual for relapse prevention in clozapine resistant schizophrenia

Crossref DOI link: https://doi.org/10.1186/s12888-025-06990-2

Published Online: 2025-05-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deicher, Anton https://orcid.org/0009-0005-3208-1532
Karl, Sebastian https://orcid.org/0000-0001-5406-7137
Otte, Marie-Luise https://orcid.org/0000-0001-5695-0716
Knabbe, Johannes https://orcid.org/0000-0003-3170-111X
Wendel, Bernadette

Gose, Maria

Wolf, R. Christian https://orcid.org/0000-0002-5358-5212
Sartorius, Alexander https://orcid.org/0000-0002-1243-3693
Funding

Funding for this research was provided by:

Medizinische Fakultät Mannheim der Universität Heidelberg
License Information

Text and Data Mining valid from 2025-05-26

Version of Record valid from 2025-05-26
More Information

Article History

Received: 12 May 2025

Accepted: 15 May 2025

First Online: 26 May 2025

Declarations

:

: The trial was approved by the Ethics Committee II of the Medical Faculty Mannheim. All patients will provide written informed consent to participate in the study.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below